Roivant Sciences Ltd. — Director's Dealing 2021

Oct 1, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2021-10-01

Reporting Person: Dexcel Pharma Technologies Ltd. (10% Owner)
Reporting Person: Dexxon Holdings Ltd. (10% Owner)
Reporting Person: Oren Dan (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	98809158	Direct

Footnotes

F1: Dexcel Pharma Technologies Ltd. ("Dexcel") is the direct beneficial holder of 643,845 common shares. Dexxon Holdings Ltd. ("Dexxon") is the direct beneficial holder of 98,165,313 common shares. Dan Oren is the Executive Chairman of Dexcel and the sole director of Dexxon and is ultimately the sole shareholder of each entity.